Summary
Plasma concentrations of the recently isolated potent vasoconstrictory peptide endothelin were measured in 382 patients. The investigations were performed by means of a sensitive radioimmunoassay specific for Endothelin-1, 2.
The results from 110 healthy volunteers displayed a normal range of 44.67±3.51 pg/ml. Significantly raised levels were found in 33 patients with chronic end-stage renal failure both before and after hemodialysis. In contrast, 35 patients with compensated renal insufficiency did not differ from the normals. Sixty-five patients after kidney transplantation revealed significantly elevated levels, as did 27 patients with acute myocardial infarction, 8 after coronary bypass surgery, and 5 with liver cirrhosis. The mean values of 27 patients with untreated hypertension, 22 with secondary hypertension, of various causes and 16 with coronary artery disease were comparable to the normal population. The values were significantly decreased in 9 pregnant women with hypertension and proteinuria. A marked decline was found in 5 patients with systemic lupus erythematodes, while 20 patients with rheumatoid arthritis demonstrated only a slight decrease.
The pathophysiological role of endothelin as a local or circulating hormone in regulating systemic blood pressure or release of other hormones remains to be determined.
Similar content being viewed by others
Abbreviations
- KHK:
-
Koronare Herzerkrankung
- EH:
-
Essentielle Hypertonie
- SH:
-
Sekundäre Hypertonie
- ANP:
-
Atrial natriuretic peptide
- Bypass-OP:
-
Koronare Bypassoperation
Literatur
Ando K, Hirata Y, Shichiri M, Emori T, Marumo F (1989) Presence of immunoreactive endothelin in human plasma. FEBS Letters 245:164–166
Asano T, Ikegaki T, Suzuki Y, Satoh S, Shibuya M (1989) Endothelin and the production of cerebral vasospasm in dogs. Biochem Biophys Res Comm 159:1345–1351
Brain SD, Tippins JR, Williams TJ (1988) Endothelin induces potent microvascular constriction. Br J Pharmacol 95:1005–1007
Cairns HS, Rogerson M, Fairbanks LD, Westwick J, Neild GH (1988) Endothelin and cyclosporin nephrotoxicity. Lancet II:1496–1497
Cernacek P, Stewart DJ (1989) Immunoreactive endothelin in human plasma marked elevations in patients in cardiogenic shock. Biochem Biophys Res Comm 161:562–567
Chester AH, Dashwood MR, Clarke JG, Larkin SW, Davies GJ, Tadjkarimi S, Maseri A, Yacoub MH (1989) Influence of endothelin on human coronary arteries and localization of its binding sites. Am J Cardiol 63:1395–1398
Davenport AP (1990) A sensitive radioimmunoassay to distinguish endothelin-1, endothelin-2 and endothelin-3 in human plasma: measurement of plasma endothelin like immunoreactivity in essential hypertension. Clin Sci (im Druck)
Davenport AP (1989) Autoradiographical localization of binding sites for porcine endothelin in rat, pig, and human: functional relevance in man. J Cardiovasc Pharmacol 13 (Suppl 5):166–170
Firth JD, Raine AEG, Ratcliffe PJ, Ledingham JGG (1988) Endothelin: an important factor in acute renal failure? Lancet II:1179–1181
Hirata Y, Itoh K, Ando K, Endo M, Marumo F (1989) Plasma endothelin levels during surgery. New Engl J Med 24:1686
Igarashi Y, Aizawa Y, Tamura M, Ebe K, Yamaguchi T, Shibata A (1989) Vasoconstrictor effect of endothelin on the canine coronary artery: is a novel endogenous peptide involved in regulating myocardial blood flow and coronary spasm? Am Heart J 118:674–678
Imnure A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T (1989) The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci 86:2863–2867
King AJ, Brenner BM, Anderson S (1989) Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol 256:1051–1058
Kon V, Yoshioka T, Fogo A, Ichikawa I (1989) Glomerular actions of endothelin in vivo. J Clin Invest 83:1762–1767
Koyama H, Nishzawa Y, Mori H, Tabata T, Inoue T, Yamaji T (1989) Plasma endothelin levels in patients with uraemia. Lancet I:991–992
Miller WL, Redfield MM, Burnett C Jr (1989) Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest 83:317–320
Miyauchi T, Yanagisawa M, Tomizawa T, Sugishita Y, Suzuki N, Fujino M, Ajisaka R, Goto K, Masaki T (1989) Increased plasma concentrations of endothelin-I and big endothelin-I in acute myocardial infarction. Lancet II:53–54
Nayler WG, Gu XH, Casley DJ, Panagiotopoulos S, Liu J, Mottram PL (1989) Cyclosporine increases endothelin-I binding site density in cardiac cell membranes. Biochem Biophys Res Commun 163:1270–1274
Saito Y, Nakao K, Itoh H, Yamada T, Mukoyama M, Arai H, Hosoda K, Shirakami G, Suga S, Jougasaki M, Morichika S, Imura H (1989) Endothelin in human plasma and culture medium of aortic endothelial cells — detection and characterization with radioimmunoassay using monoclonal antibody. Biochem Biophys Res Comm 161:320–326
Saito Y, Nakao K, Mukoyama M, Imura H (1990) Increased plasma endothelin level in patients with essential hypertension. New Engl J Med 3:205
Schini VB, Hendrickson H, Heublein DM, Burnett JC Jr, Vanhoutte PM (1989) Thrombin enhances the release of endothelin from cultured porcine aortic endothelial cells. Eur J Pharmacol 165:333–334
Schrader J, Gallimore MJ, Eisenhauer T, Isemer FE, Schoel G, Warneke G, Brüggemann M, Scheler F (1988) Parameters of the Kallikrein-Kinin, Coagulation and Fibrinolytic Systems as Early Indicators of Kidney Transplant Rejection Nephron 48:183–189
Sugiura M, Inagami T, Kon V (1989) Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Comm 161:1220–1227
Tomita K, Ujiie K, Nakanishi T, Tomura S, Matsuda O, Ando K, Shichiri M, Hirata Y, Marumo F (1989) Plasma endothelin levels in patients with acute renal failure. New Engl J Med 16:1127
Totsune K, Mouri T, Takahashi K, Ohneda M, Sone M, Saito T, Yoshinaga K (1989) Detection of immunoreactive endothelin in plasma of hemodialysis patients. FEBS Letters 249:239–242
Yanagisawa M, Inoue A, Ishikawa T, Kasuya Y, Kimura S, Kumagaye SI, Nakajima K, Watanabe TX, Sakakibara S, Goto K, Masaki T (1988) Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci 85:6964–6967
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415
Yanagisawa M, Masaki T (1989) Endothelin, a novel endothelium-derived peptide. Pharmacological activities, regulation and possible roles in cardiovascular control. Biochem Pharmacol 38:1877–1883
Author information
Authors and Affiliations
Additional information
Herrn Prof. Dr. med. F. Scheler zum 65. Geburtstag gewidmet.
Rights and permissions
About this article
Cite this article
Schrader, J., Tebbe, U., Borries, M. et al. Plasma-Endothelin bei Normalpersonen und Patienten mit nephrologisch-rheumatologischen und kardiovaskulären Erkrankungen. Klin Wochenschr 68, 774–779 (1990). https://doi.org/10.1007/BF01647248
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01647248